Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

NCT04898387 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.

NCT NCT04898387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.
Lead sponsor
Laboratoires Thea
Phase
Phase 3
Overall status
Completed
Start date
March 26, 2021
Completion date
May 30, 2023
Enrollment
554 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension glaucoma